These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1464 related items for PubMed ID: 14730619

  • 1. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signalling pathways in human dermal fibroblasts.
    Zhang GY, Li X, Yi CG, Pan H, He GD, Yu Q, Jiang LF, Xu WH, Li ZJ, Ding J, Lin DS, Gao WY.
    Exp Dermatol; 2009 Nov; 18(11):947-53. PubMed ID: 19397700
    [Abstract] [Full Text] [Related]

  • 3. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
    Kawaguchi Y, Harigai M, Hara M, Fukasawa C, Takagi K, Tanaka M, Tanaka E, Nishimagi E, Kamatani N.
    J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
    [Abstract] [Full Text] [Related]

  • 4. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T, Kähäri VM, Black C, Vuorio E.
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [Abstract] [Full Text] [Related]

  • 5. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J, Gore-Hyer E, Yamanaka M, Smith EA, Rubinchik S, Dong JY, Jablonska S, Blaszczyk M, Trojanowska M.
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [Abstract] [Full Text] [Related]

  • 6. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J, Gardner H, Shearstone JR, Smith E, Trojanowska M.
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [Abstract] [Full Text] [Related]

  • 7. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
    Distler JH, Jüngel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci-Cerinic M, Schett G, Marti HH, Gay S, Distler O.
    Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
    [Abstract] [Full Text] [Related]

  • 8. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A, Korn JH.
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [Abstract] [Full Text] [Related]

  • 9. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N, Maurer B, Akhmetshina A, Venalis P, Dees C, Zerr P, Palumbo K, Zwerina J, Nevskaya T, Gay S, Distler O, Schett G, Distler JH.
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C, Rezzonico R, Ribbens C, Burger D, Wollheim FA, Dayer JM.
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [Abstract] [Full Text] [Related]

  • 11. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S, Ghosh AK, Pannu J, Mori Y, Takagawa S, Chen G, Trojanowska M, Gilliam AC, Varga J.
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [Abstract] [Full Text] [Related]

  • 12. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
    Postiglione L, Ladogana P, Montagnani S, di Spigna G, Castaldo C, Turano M, Bruno EM, Di Meglio F, Riccio A, Rossi G.
    J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
    [Abstract] [Full Text] [Related]

  • 13. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
    Nakashima T, Jinnin M, Yamane K, Honda N, Kajihara I, Makino T, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H.
    J Immunol; 2012 Apr 15; 188(8):3573-83. PubMed ID: 22403442
    [Abstract] [Full Text] [Related]

  • 14. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse.
    Ong VH, Evans LA, Shiwen X, Fisher IB, Rajkumar V, Abraham DJ, Black CM, Denton CP.
    Arthritis Rheum; 2003 Jul 15; 48(7):1979-91. PubMed ID: 12847692
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
    Ihn H, Yamane K, Kubo M, Tamaki K.
    Arthritis Rheum; 2001 Feb 15; 44(2):474-80. PubMed ID: 11229480
    [Abstract] [Full Text] [Related]

  • 17. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
    J Cell Physiol; 2005 May 15; 203(2):447-56. PubMed ID: 15605379
    [Abstract] [Full Text] [Related]

  • 18. Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis.
    Kubo M, Ihn H, Yamane K, Tamaki K.
    J Rheumatol; 2002 Dec 15; 29(12):2558-64. PubMed ID: 12465152
    [Abstract] [Full Text] [Related]

  • 19. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis.
    Huber LC, Distler JH, Moritz F, Hemmatazad H, Hauser T, Michel BA, Gay RE, Matucci-Cerinic M, Gay S, Distler O, Jüngel A.
    Arthritis Rheum; 2007 Aug 15; 56(8):2755-64. PubMed ID: 17665426
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.